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ANIMAL MODELS DEMONSTRATING RESPIRATORY RESPONSES
TO INHALANT ANTIGENS**
The availability of animal systems representative of various pulmonary
hypersensitivity reactions in man would be useful in several areas of study.
Such animal models of respiratory disease resulting from immune mecha-
nisms could be classified in several ways. One approach is to categorize
the reaction by the major type of immune reaction involved. These include
responses due to immediate type (wheal and erythema, reaginic) hyper-
sensitivity, responses presumed due to precipitating type of antibodies,
and responses due to delayed (cellular) hypersensitivity. Other possible
reactions could result from antigen-antibody complexes or from auto-
immune reactions due to antibody directed against pulmonary tissue.
Finally, reactions could result from combinations of two or more of the
above types of immune substances directed against the same antigen.
Pulmonary reactions resulting from the reaginic of antibody are common
clinical phenomena and are reproducible under experimental conditions.
These reactions will be described in detail. Reactions from precipitating
antibody almost certainly occur and presumably account for certain types
of infiltrative lung disease. The same type of antibodies in the presence of
excess antigen would form soluble antigen-antibody complexes and it is not
unlikely that these complexes may play a role in certain types of infiltrative
lung disease. Delayed hypersentivity as a mechanism of production of
chronic pulmonary disease is even less well defined. Hypersensitivity of
this type to inhaled organic or inorganic material or to microbial antigens
may be related to various pulmonary reactions.
In a second approach, the type of model desired might be classified by
the type of pulmonary disease it is expected to simulate. Acute or chronic
reversible airway obstructive changes analogous, to some extent, to human
asthma can be produced. Infiltrative lung reactions analogous to certain
inhalation diseases (Farmer's Lung, Pigeon Breeder's Disease) should
be possible to duplicate in animals when the proper conditions are estab-
lished. These conditions would include the appropriate hyperimmune state
of the animal, achieved by immunization procedures directed toward pro-
duction of sufficient amounts of the required antibody. In addition, delivery
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of the antigen by methods such that its physical state, concentration, and
route of administration simulate conditions of natural exposure may be
requirements for the development of local tissue damage.
There has been no evidence arising from clinical or experimental studies
which demonstrates that the chronic irreversible lung disease termed pul-
monary emphysema is the result of a hypersensitivity reaction to any of
the immunologic mechanisms described above. Until the etiology of the
irreversible airway disease is established, the possibility that immunologic
mechanisms may play a primary or contributing factor is not excluded.
Finally, the third type of approach to establishment of animal systems
could be directed toward the reproduction of those pathological or physio-
logic changes that have been described in pulmonary disease proven or
presumed to be due to immune mechanisms. Whether or not the primary
direction is toward reproduction of histologic changes, those tissue changes
occurring in the human disease state should be observed in animal disease
simulating its counterpart in man. The remainder of this report concerns
animal systems developed for study of reaginic allergy.
ANIMAL MODELS OF ACUTE RESPIRATORY RESPONSES TO ANTIGENS
For several years, work in our laboratory has involved the study of
immediate type hypersensitivity disease as it occurs spontaneously in man
and animals in response to environmental antigens. These studies have
included observations on the comparative immunology of reaginic anti-
body,1 characterization of certain antigens2 and reactions of these antigens
with reaginic antibodies,3 mediator release from leukocytes as a result of
reaginic antibody and antigen interaction,' and certain factors affecting
such immunologically mediated histamine release.!
One major direction of study has been the description of the biologic
results of in vivo reactions of reaginic antibody with specific antigens (more
completely reviewed elsewhere).' The present report describes one area
of these studies and application of these studies to the production of acute
models of respiratory reactions. The type of respiratory response under
study is not considered to be one responsible for the production of chronic
irreversible obstructive lung disease in man. The acute respiratory response
is thought to be representative of acute, antibody-mediated reactions of
the respiratory tract which are analogous to certain hypersensitivity re-
actions of the human respiratory tract. In man, this type of reaction may
produce chronic, reversible, obstructive airway disease.
We have developed three systems of airway response that produce
demonstrable alterations in respiratory physiology. Each system will be
described briefly and will be discussed in terms of its reproducibility,
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availability, the characterization of its immunologic aspects, problems in
application, and limitations in utilization.
Canine reaginic allergy
Immediate type reactivity to pollen and other environmental antigens
occurs in dogs. The spontaneous allergic disease in dogs is characterized
clinically by the seasonal occurrence of dermatitis, rhinitis, conjunctivitis,
or asthma.
There are similarities and differences between the seasonal allergic
disease in dog and man. Similarities include the type of antigens responsi-
ble for the reactions and the immunologic basis for the disease. One major
difference is the high incidence of seasonal dermatitis in dogs while the
allergic reaction in man is primarily in the respiratory tract. The environ-
mental etiologic factors in human seasonal allergic respiratory disease are
relatively easily defined. Etiologic factors in dogs in all cases of seasonal
dermatitis, with the exception of ragweed pollinosis, are more difficult to
determine, and some of these cases of seasonal dermatitis may not be hy-
persensitivity reactions. The reaginic antibody in dogs with proven rag-
weed pollinosis has been characterized by most methods applied to the
study of human reaginic antibody, and the physico-chemical properties of
the canine reagin are similar to those of human reagin.16 Characterization
of the canine reagin has been limited by lack of availability of preparations
of pure canine immunoglobulins and the monospecific antisera which can be
prepared against such purified preparations. Preliminary studies have led
us to suggest that canine reaginic antibody against environmental antigens
is located in a canine immunoglobulin type that is analogous to IgE of
man.7
The degree of hypersensitivity of an allergic dog may be demonstrated
by transfer of cutaneous reactivity to the skin of normal dogs by dilutions
of the reaginic serum. When a dog with a sufficient degree of hypersensi-
tivity to ragweed is challenged by means of an aerosol of ragweed antigen,
symptoms of acute dyspnea occur and provide a canine model of acute
respiratory reaction to inhaled antigen. The bronchial response is repro-
ducible and has been observed under controlled conditions in five dogs
with ragweed sensitivity. The bronchial reactivity appears persistent since
it has been repeatedly demonstrated in one dog over a period of nine years.
Physiologic measurements and quantitative antigenic challenge are pos-
sible but not easily accomplished in the unanesthetized allergic dog.
Antigenic challenge by aerosolized antigen following administration of
anesthesia given to prepare the subject for physiologic measurements and
controlled aerosol challenge may result in sudden death. The animals avail-
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able are limited in number and all dogs with reaginic antibody may not
react with a bronchial response. It is possible that this difference in bron-
chial response in ragweed sensitive dogs may be the result of inherited
or acquired variations in the sensitivity of the respiratory tract not medi-
ated by immunologic mechanisms. However, the only correlation that has
appeared in the limited studies possible is the smaller amount of circulating
reaginic antibody in those dogs not responding to aerosol challenge with
specific antigen.
The number of allergic dogs available for repeated studies is small.
While canine reaginic allergy is not rare,8 few animals are made available
for laboratory study. Current attempts by our research unit to develop in-
bred strains of dogs with the tendency to develop reaginic disease are in
progress, but development of this project has been limited by the avail-
ability of breeding stock and by the availability of methods of assessment
of the development of the desired sensitivity.
A related canine reaginic system more immediately available is depen-
dant upon the passive sensitization of normal dogs with canine reaginic
antisera. The intravenous administration of an appropriate amount of
reaginic serum containing a sufficient antibody titer results in transient
systemic sensitivity of the recipient dog. Following the passive sensitiza-
tion, the recipient animal has cutaneous, anaphylactic or bronchial reactivity
depending on the route of antigenic challenge. When such a dog is anes-
thetized and challenged under controlled conditions by administration of
aerosolized antigen, alterations in pulmonary physiology are detectable.
The measureable changes include alterations in breathing frequency, tidal
volume, maximal expiratory flow rate and ratios of expiratory to inspira-
tory periods. The findings are considered consistent with the production of
acute, reversible obstructive airway changes. The system has been repro-
ducible in the same or different recipients. There are two major limitations
in use of the passively sensitized dog system. These include the desensitiza-
tion that follows sufficient exposure to antigen in an experiment that re-
quires repeated sensitization for subsequent experiments, and the lack of
availability of large amounts of high titered canine reaginic sera.
Passive sensitization of sub-human prinwtes with human reaginic sera
Rhesus and other monkeys can be passively sensitized locally or sys-
temically with human reaginic sera. Intravenous challenge following
systemic sensitization of the monkeys results in anaphylaxis during which
the clinical manifestations are similar to those of man. The physiologic and
histologic abnormalities occurring during and after monkey anaphylaxis
have been described.9"10 When the rhesus monkeys, passively sensitized
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with human reaginic serum, are challenged with specific antigen by aerosol,
alterations in respiratory function similar to those in the dog system occur.
These respiratory function changes are measured during antigenic chal-
lenge in the anesthetized state and consist of increased breathing frequency,
a decrease in tidal volume and maximal expiratory flow rate. In some ani-
mals, prolongation of the expiratory phase of respiration was observed.
During severe respiratory responses in which blood gas concentrations were
determined, there were decreases in arterial oxygen and increases in ar-
terial carbon dioxide concentrations. The results of these experiments were
consistent with the occurrence of acute obstructive reversible airflow ob-
struction as a result of the reaction of antigen and reaginic antibody in the
bronchial mucosa. The histopathology of such sites have not been studied.
The system is reproducible provided that there is appropriate selection of
human donor and provided the recipient is tested by local cutaneous sen-
sitization and shown to be a suitable recipient for sensitization by human
reaginic antibody. A limitation of the system is the desensitization of the
sensitized monkey by exposure of the animal to antigen. This requires re-
peated sensitization for a second experiment. There is a limited number
of times an animal can be used for passive sensitization, because the human
sera results in active sensitization of the monkey. The development of an-
tibodies by the monkey against human reagin inhibits subsequent passive
sensitization with human serum.
Active reaginic sensitivity of the monkey
The ideal model of reaginic sensitivity for laboratory study would be
extrinsic sensitivity of the monkey to inhaled environmental antigens.
While it may be predicted that such reactivity exists, it has not yet been
described. We have studied the occurrence of immediate reactivity of
rhesus monkeys to ascaris antigen and found a significant incidence of
ascaris sensitivity among an unselected population of monkeys.1' The mon-
keys demonstrating a sufficient degree of ascaris sensitivity react with
cutaneous, anaphylactic, and bronchial reactivity to specific challenge with
ascaris antigen. The particular clinical response depends on whether the
antigenic challenge is given by the cutaneous, intravenous, or bronchial
route. The initial studies of bronchial reactivity of these monkeys demon-
strate a reproducible airway response with all characteristics of the other
two (dog and monkey) systems.1' These monkeys characteristically de-
velop expiratory rales and wheezes during the acute phase of respiratory
response. The reactivity has been shown to be related to a serum antibody
that is thermolabile, non-precipitable, skin-sensitizing and localized between
the first two peaks of a Sephadex G-200 chromatographic preparation. The
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antibody against ascaris thus has many of the characteristics of human
reaginic antibody. Limitations of the system are lack of characterization
and purification of ascaris antigens. The possibility that a component of
certain of the reactions is due to nonimmunologic chemically mediated re-
actions has not been excluded. In spite of this, the ascaris model of bron-
chial reactivity probably has the most potential for study of respiratory
responses because of its availability and reproducibility in the same subject.
SUMMARY
Three systems of reproducible airway obstructive changes occurring as
a result of specific reaginic antibody-antigen reactions are described. These
systems produce measurable physiologic alterations in experimental sub-
jects under controlled conditions. They provide a system for study of acute
respiratory failure and for the study of changes that occur in certain
chronic respiratory obstructive diseases.
REFERENCES
1. Patterson, R., Pruzansky, J. J., and Chang, W. W. Y.: Spontaneous canine hy-
persensitivity to ragweed. Characterization of the serum factor transferring
skin, bronchial and anaphylactic sensitivity. J. Immuwol., 1963, 90, 35.
2. Patterson, R., Pruzansky, J. J., and Feinberg, S. M.: Studies on reactions of
human allergic serum with serum protein antigens. I. Method of passive im-
mune elimination and gel diffusion autoradiography. J. Allergy, 1962, 33, 236.
3. Pruzansky, J. J., Patterson, R., and Feinberg, S. M.: Studies on reactions of
human allergic serum with serum protein antigens. II. Methods of quantita-
tive demonstration by a coprecipitation technique. J. Allergy, 1962, 33, 281.
4. Pruzansky, J. J. and Patterson, R.: The interaction of antigen with leucocytes
of allergic individuals. J. Immunol., 1966, 97, 854.
5. Pruzansky, J. J. and Patterson, R.: The subcellular distribution of histamine in
human leucocytes. Proc. Soc. exp. Biol. (N.Y.), 1967, 124, 56.
6. Rockey, J. H. and Schwartzman, R. M.: Skin sensitizing antibodies: A com-
parative study of canine and human PK and PCA antibodies and a canine
myelome protein. J. Immunol., 1967, 98, 1143.
7. Patterson, R.: Laboratory models of reaginic allergy. In, Progress in Allergy,
edited by P. Kallos and B. H. Waksman. Basel, S. Karger, (in press).
8. Patterson, R., Chang, W. W. Y., and Pruzansky, J. J.: The Northwestern Uni-
versity colony of atopic dogs. J. Allergy, 1963, 34, 455.
9. Patterson, R., Fink, J. N., Nishimura, E. T., and Pruzansky, J. J.: The passive
transfer of immediate type hypersensitivity from man to other primates. J.
clin. Invest., 1965, 44, 140.
10. Weiszer, I., Patterson, R., and Pruzansky, J. J.: Ascaris hypersensitivity in the
Rhesus monkey. I. A model for the study of immediate type hypersensitivity
in the primate, J. Allergy, 1968, 41, 14.
11. Patterson, R. and Weiszer, I.: Respiratory responses in the ascaris sensitive
Rhesus monkey. (To be published.)
500